Thanks Jim and good afternoon. This afternoon the company filed its Form 10-Q for the quarter ended September 30, 2024 with the SEC. As I always do, I recommend you read this filing in its entirety. I will share details on the full company results, operational EBITDA and cash flow for the third quarter and nine months ending September 30, 2024. The company's results reflect the continued focus on executing against our priorities and long-term plan, including driving smart revenue and aligning with the right customers, pricing rationalization, cost reductions, launching new products, and investing in innovation and information technology systems. The company's financial results are within our expectations at this point in our long-term strategy and for the current year. On slide seven, reported revenues of $261 million for the third quarter of 2024, compared to $269 million in the prior year quarter, a decrease of $8 million or 3%. The decline in revenues slowed notably when compared to recent quarters, reflecting our ongoing focus on driving smart revenue and strong profitability. On a constant currency basis, revenue declined by $9 million, compared to the prior year quarter. Gross profit decreased by $5 million or 10% when compared to the prior year quarter. Gross profit for the current year quarter was unfavorably impacted by a net change in employee benefit reserves of $3 million, an inventory reserve adjustment of $4 million in the Electrophotographic Printing Solutions business, and higher aluminum costs of $5 million. Foreign exchange had no impact on gross profit in the current year quarter. Our gross profit percentage was 17% in the third quarter of 2024, compared to 19% in the prior year quarter, unfavorably impacted by the factors previously noted. On a U.S. GAAP basis, we reported net income of $18 million for the third quarter of 2024, compared to net income of $2 million in the prior year quarter, an increase of $16 million. The 2024 and 2023 third quarter results include expense of $2 million and income of $3 million respectively, related to non-cash changes in workers’ compensation and employee benefit reserves. The prior year quarter also includes a loss on extinguishment of debt of $27 million resulting from a refinancing transaction. Excluding these current and prior year quarter items, net income for 2024 was $20 million, compared to net income of $26 million in the prior year quarter. Operational EBITDA for the quarter was $1 million, compared to $12 million in the prior year quarter. Excluding the impact of non-cash changes in workers' compensation and employee benefit reserves in the current and prior year quarters, operational EBITDA declined by $6 million when compared to the prior year quarter. Foreign exchange had no impact on operational EBITDA in the current year quarter. Operational EBITDA for the third quarter of 2024 was also unfavorably impacted by higher manufacturing costs driven by an increase in aluminum costs, changes in employee benefit reserves, an inventory reserve adjustment, as well as an increase in costs associated with certain litigation matters. Turning to slide eight. For the nine months ending September 30, 2024, we reported revenues of $777 million, compared to $842 million in the prior year period for a decline of $65 million or 8%. Adjusting for the unfavorable impact of foreign exchange of $3 million in the current year period, revenue decreased by $62 million or 7%, when compared to the prior year period. Gross profit decreased by $11 million or 7% when compared to the prior year period. Gross profit for the current year was unfavorably impacted by a net change in employee benefit reserves of $2 million, an inventory reserve adjustment of $4 million in the Electrophotographic Printing Solutions business, and higher aluminum costs of $1 million. Foreign exchange had no impact on gross profit in the current year period. Our gross profit percentage was 20% for the nine months ending September 30, 2024, compared to 19% in the prior year period. On a U.S. GAAP basis, net income was $76 million for the nine months ending September 30, 2024, compared to net income of $70 million in the prior year period, an increase of $6 million. The 2024 year-to-date results include expense of $1 million related to non-cash changes in workers' compensation and employee benefit reserves, and income of $17 million related to a net gain on the sale of assets. The 2023 year-to-date results include charges of $2 million related to changes in the fair value of embedded derivative liabilities and $27 million related to a loss in the extinguishment of debt, an income of $9 million related to a refund from a non-U.S. Governmental authority, and $3 million related to non-cash changes in workers' compensation and employee benefit reserves. Excluding these current and prior year items, net income for the nine months ending September 30, 2024, was $60 million, compared to net income of $87 million in the prior year period, a decline of $27 million. Operational EBITDA for the period was $17 million, compared to $43 million in the prior year period, a decline of $26 million. Excluding the impact of non-cash changes in workers' compensation and employee benefit reserves in the current and prior year periods, operational EBITDA decreased by $22 million, compared to the prior year period. Foreign exchange had no impact on operational EBITDA in the current year period. Operational EBITDA for the current year period was unfavorably impacted by lower volumes and higher manufacturing costs, and inventory reserve adjustment, changes in employee benefit reserves, higher selling and administrative costs associated with investments in information technology systems, and organizational structure improvements to drive further operational efficiencies, as well as costs associated with the drupa trade show and certain litigation matters. Moving on to the company's cash performance presented on slide nine, the company ended the third quarter with $214 million in cash and cash equivalents, a decrease of $41 million from December 31, 2023, which is in line with our expectations. The decline reflects our continued CapEx investments in supporting AM&C growth initiatives along with building working capital in this business to allow us to supply customers as we make improvements in our manufacturing facilities. For the nine months ending September 30, 2024, cash used in operating activities was $11 million, primarily driven by a use of cash from net earnings of $25 million, partially offset by cash flow from balance sheet changes of $14 million, including a change in working capital of $26 million and a decrease in other liabilities of $39 million. Within working capital, accounts payable decreased by $1 million, inventory increased by $25 million, and accounts receivable decreased by $52 million, compared to the prior year period. The decrease in accounts receivable is primarily due to $40 million of cash proceeds received in January 2024 from brand licensing. The team continues to focus on improving profitability and performance in working capital, which enhances the company's ability to generate cash. Cash used in investing activities was $22 million for the nine-month ending September 30, 2024, an increase of $7 million, when compared to the prior year period, primarily due to an increase in capital additions of $24 million, partially offset by proceeds from the sale of assets of $17 million. Cash used in financing activities was $21 million for the nine months ending September 30, 2024, compared to cash provided by financing activities of $87 million in the prior year period. This change was primarily driven by net proceeds of $90 million received from refinancing transactions in the prior year period and $17 million related to the repayment of the amended and restated term loan agreement made during the first quarter of 2024 from the proceeds received from the sale of assets within investing activities. Restricted cash decreased by 14 million dollars when compared to the balance of $122 million as of December 31, 2023, primarily driven by strategic efforts to reduce cash collateral and escrow requirements for certain company obligations and business arrangements. As a reminder, restricted cash primarily represents cash collateral supporting the company's undiscounted actuarial workers' compensation obligations with the New York State Workers' Compensation Board and cash collateral required under the Letter of Credit Facility in addition to escrow to secure various ongoing obligations. We will continue to focus on alternatives to reduce restrictions on cash. As presented on the bottom portion of the slide, excluding the effects of foreign exchange, prior year period impact of a refund from a non-U.S. Governmental authority and net proceeds from refinancing transactions, the year-over-year decrease in cash and cash equivalents was $34 million. As stated earlier in my remarks, the company's financial results are within our expectations at this point in our long-term strategy. We will continue to focus on maintaining the strength of the foundation we have worked hard to create, which provides us the opportunity to fund our ongoing operations and invest in growth opportunities to continue to execute our strategy. Finally, we remain in compliance with applicable financial covenants. I will now turn the discussion back to Jim.